dapagliflozin
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
33342-586 -
Package NDC
33342-586-07 -
Package NDC
33342-586-10 -
Package NDC
33342-586-56 -
Application number
ANDA211506 -
SPL ID
31e8764a-d64a-4282-8072-9fd6b7c24ea4 -
SPL set ID
91373924-66dc-4277-aaf2-8536e81a0e4d -
UNII
1ULL0QJ8UC -
RxCUI
1488569 -
RxCUI
1488574
What the source publishes
- Labeler
- Macleods Pharmaceuticals Limited
- Active ingredients
- dapagliflozin
- Form
- TABLET
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "dapagliflozin",
"splId": "31e8764a-d64a-4282-8072-9fd6b7c24ea4",
"labels": [
{
"setId": "91373924-66dc-4277-aaf2-8536e81a0e4d",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=91373924-66dc-4277-aaf2-8536e81a0e4d",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=91373924-66dc-4277-aaf2-8536e81a0e4d"
}
],
"routes": [
"ORAL"
],
"labeler": "Macleods Pharmaceuticals Limited",
"finished": true,
"packaging": [
{
"sample": false,
"description": "30 TABLET in 1 BOTTLE (33342-586-07)",
"package_ndc": "33342-586-07",
"identifierStatus": "well-formed",
"marketing_start_date": "20260406"
},
{
"sample": false,
"description": "90 TABLET in 1 BOTTLE (33342-586-10)",
"package_ndc": "33342-586-10",
"identifierStatus": "well-formed",
"marketing_start_date": "20260406"
},
{
"sample": false,
"description": "10 BLISTER PACK in 1 CARTON (33342-586-56) / 14 TABLET in 1 BLISTER PACK (33342-586-66)",
"package_ndc": "33342-586-56",
"identifierStatus": "well-formed",
"marketing_start_date": "20260406"
}
],
"productId": "33342-586_31e8764a-d64a-4282-8072-9fd6b7c24ea4",
"useDomain": "unknown",
"dosageForm": "TABLET",
"productNdc": "33342-586",
"deaSchedule": null,
"genericName": "dapagliflozin",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "DAPAGLIFLOZIN",
"strength": "10 mg/1"
}
],
"applicationNumber": "ANDA211506",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20260406",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000187059",
"N0000187058"
],
"upc": [
"0333342586070",
"0333342586100",
"0333342585073",
"0333342585103"
],
"unii": [
"1ULL0QJ8UC"
],
"rxcui": [
"1488569",
"1488574"
],
"spl_set_id": [
"91373924-66dc-4277-aaf2-8536e81a0e4d"
],
"pharm_class_epc": [
"Sodium-Glucose Cotransporter 2 Inhibitor [EPC]"
],
"pharm_class_moa": [
"Sodium-Glucose Transporter 2 Inhibitors [MoA]"
],
"manufacturer_name": [
"Macleods Pharmaceuticals Limited"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:33342-586_31e8764a-d64a-4282-8072-9fd6b7c24ea4"